Uses of Radiopharmaceuticals in Nuclear Medicine
- 1 January 1992
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agentThe American Journal of Cardiology, 1990
- Enhanced Detection of Ischemic but Viable Myocardium by the Reinjection of Thallium after Stress-Redistribution ImagingNew England Journal of Medicine, 1990
- Myocardial metabolism by positron emission tomography in hypertrophic cardiomyopathyJournal of the American College of Cardiology, 1989
- Late reversibility of tomographic myocardial thallium-201 defects: An accurate marker of myocardial viabilityJournal of the American College of Cardiology, 1988
- Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody.Circulation, 1986
- N-13 ammonia as an indicator of myocardial blood flow.Circulation, 1981
- Experimental and Clinical Trials of New99mTc-Labeled Hepatobiliary AgentsRadiology, 1978
- Technetium-99m DTPA: A New Radiopharmaceutical for Brain and Kidney ScanningRadiology, 1970
- Volumes of Distribution and Clearances of Intravenously Injected Creatinine in the DogAmerican Journal of Physiology-Legacy Content, 1955